← All stocks

Kairos Pharma, LTD.

KAPA No buying or selling

CIK 0001962011 #5350 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

7 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Bhowmick Neil

Chief Scientific Officer

—

1,311,739

$2.09M

+16.5%

Murali Ramachandran

VP of Research and Development

—

299,529

$476.25K

+125.8%

Samuelson Doug

Chief Financial Officer

—

293,039

$465.93K

+112.6%

Yu John S

CEO and Chairman

—

230,105

$365.87K

+982.1%

Bae Hyun W.

Director

—

73,370

$116.66K

+65.7%

Singhvi Rahul

Director

—

49,204

$78.23K

+63.4%

Keyoung Hansoo Michael

Director

—

29,084

$46.24K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 21 Nov 2024